A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
Clinical trial NCT02651675 · TERMINATED
Trial details
- NCT number
- NCT02651675
- Sponsor
- REGENXBIO Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-11-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.